Invention Grant
- Patent Title: Enantiomerically pure phosphoindoles as HIV inhibitors
- Patent Title (中): 对映异构纯的磷酸吲哚作为HIV抑制剂
-
Application No.: US13152018Application Date: 2011-06-02
-
Publication No.: US08486991B2Publication Date: 2013-07-16
- Inventor: Richard Storer , Francois-Rene Alexandre , Cyril Dousson , Adel M. Moussa , Edward Bridges , Alistair Stewart , Jing Yang Wang , Benjamin Alexander Mayes
- Applicant: Richard Storer , Francois-Rene Alexandre , Cyril Dousson , Adel M. Moussa , Edward Bridges , Alistair Stewart , Jing Yang Wang , Benjamin Alexander Mayes
- Applicant Address: US MA Cambridge
- Assignee: Idenix Pharmaceuticals, Inc.
- Current Assignee: Idenix Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Jones Day
- Main IPC: A61K31/40
- IPC: A61K31/40
Abstract:
3-phosphoindole compounds substantially in the form of a single enantiomer useful for the treatment of Flaviviridae virus infections, and particularly for HIV infections are provided. Also provided are pharmaceutical compositions comprising the 3-phosphoindole compounds alone or in combination with one or more other anti-viral agents, processes for their preparation, and methods of manufacturing a medicament incorporating these compounds.
Public/Granted literature
- US20110257129A1 ENANTIOMERICALLY PURE PHOSPHOINDOLES AS HIV INHIBITORS Public/Granted day:2011-10-20
Information query
